Biomarkers can predict return of thyroid cancer; Researchers seeking biomarkers for poor pregnancy outcomes;

> Investigators in Australia report that a pair of microRNA biomarkers can predict the likely recurrence of papillary thyroid cancer. Story

> A team of researchers is working on identifying angiogenic biomarkers that can provide an early warning of poor pregnancy outcomes. Report (reg. req.)

> New meta-analysis has verified that the XRCC1 Arg399Gln polymorphism may be a good biomarker of a risk for glioma, especially among Asians. The work highlights the importance of new screening efforts. Report

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.